Abstract
The mechanisms of action and structural determinants of lipoxygenases inhibitors have been explored on several occasions, but many questions remain unanswered, especially about the differences of the inhibition mechanisms and their effect on the selectivity of lipoxygenases isoenzymes. Thus, REDOX mechanism has been proposed in this research to clarify the lipoxygenases inhibition by coumarins derivates on 15-sLOX. A series of fifteen coumarin derivatives were synthetized and evaluated as 15-lipoxygenase inhibitors. The results showed that some molecules had submicromolar activities and compete with the substrate as we observed by kinetic studies. The most relevant and interesting result was found for compound 6 who showed an inhibitory activity comparable to nordihydroguaiaretic acid a potent and REDOX inhibitor of lipoxygenases (0.17 and 0.29 μM, respectively). Finally, the docking and molecular dynamics studies showed that the better ligands were accommodated into the binding site being related with those obtained biological data. In addition, our findings contribute at the understanding of inhibitor structural requirements and elucidate the inhibition mechanism of cumarin derivatives on 15-sLOX. Thus, we point to new parameters for the future design of new ligands with potential therapeutic utility where are involved the lipoxygenases enzymes.
Similar content being viewed by others
References
Aliaga ME, Tiznado W, Cassels BK, Nunez MT, Millán D, Pérez EG, García-Beltrán O, Pavez P (2014) Substituent effects on reactivity of 3-cinnamoylcoumarins with thiols of biological interest. RSC Adv 4:697–704
Armstrong MM, Diaz G, Kenyon V, Holman TR (2014) Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes. Bioorg Med Chem 22:4293–4297
Bansal Y, Sethi P, Bansal G (2013) Coumarin: a potential nucleus for anti-inflammatory molecules. Med Chem Res 22:3049–3060
Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW (1992) The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor. Int J Immunopharmacol 14:505–510
Berman J, Westbrook Z, Feng G, Gilliland TN, Bhat H, Weissig IN, Shindyalov PE (2000) The protein data bank. Nucleic Acids Res 28:235–242
Borbulevych OY, Jankun J, Selman SH, Skrzypczak‐Jankun E (2004) Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X‐ray structure at 2.1 Å resolution. Proteins 54:13–19
Brash AR, Schneider C, Hamberg M (2012) Applications of stereospecifically-labeled fatty acids in oxygenase and desaturase biochemistry. Lipids 47:101–116
Carroll J, Jonsson EN, Ebel R, Hartman MS, Holman TR, Crews P (2001) Probing sponge-derived terpenoids for human 15-lipoxygenase inhibitors. JOC 66:6847–6851
Chauhan BF, Ducharme FM (2012) Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. The Cochrane Library
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Choi J, Chon JK, Kim S, Shin W (2008) Conformational flexibility in mammalian 15S-lipoxygenase: reinterpretation of the crystallographic data. Proteins 70(3):1023–1032
Deschamps JD, Gautschi JT, Whitman S, Johnson TA, Gassner NC, Crews P, Holman TR (2007) Discovery of platelet-type 12-human lipoxygenase selective inhibitors by high-throughput screening of structurally diverse libraries. Bioorg Med Chem 15:6900–6908
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr., Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009) Gaussian ‘09, Revision A.1. ’09. Wallingford, CT
García-Beltrán O, Cassels BK, Pérez C, Mena N, Núñez MT, Martínez NP, Aliaga ME (2014) Coumarin-based fluorescent probes for dual recognition of copper (II) and iron (III) ions and their application in bio-imaging. Sensors 14:1358–1371
García-Beltrán O, Mena N, Berríos TA, Castro EA, Cassels BK, Núñez MT, Aliaga ME (2012a) A selective fluorescent probe for the detection of mercury (II) in aqueous media and its applications in living cells. Tetrahedron Lett 53:6598–6601
García-Beltran O, Mena N, Friedrich LC, Netto-Ferreira JC, Vargas V, Quina FH, Cassels BK (2012b) Design and synthesis of a new coumarin-based ‘turn-on fluorescent probe selective for Cu+2. Tetrahedron Lett 2012(53):5280–5283
García-Beltrán O, Mena N, Yañez O, Caballero J, Vargas V, Nuñez MT, Cassels BK (2013) Design, synthesis and cellular dynamics studies in membranes of a new coumarin-based “turn-off” fluorescent probe selective for Fe 2+. Eur J Med Chem 67:60–63
García-Beltrán O, Rodríguez A, Trujillo A, Cañete A, Aguirre P, Gallego-Quintero S, Aliaga ME (2015a) Synthesis and characterization of a novel fluorescent and colorimetric probe for the detection of mercury (II) even in the presence of relevant biothiols. Tetrahedron Lett 56:5761–5766
García-Beltrán O, Rodríguez A, Trujillo A, Cañete A, Aguirre P, Gallego-Quintero S, Aliaga ME (2015b) Synthesis and characterization of a novel fluorescent and colorimetric probe for the detection of mercury (II) even in the presence of relevant biothiols. Tetrahedron Lett 56:5761–5766
Dennington R, Keith T, Millam J (2009) GaussView, Version 5 Semichem Inc., Shawnee Mission, KS,
Giannopoulos PF, Joshi YB, Chu J, Praticò D (2013) The 12‐15‐lipoxygenase is a modulator of Alzheimer’s‐related tau pathology in vivo. Aging Cell 12:1082–1090
Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, Brash AR, Newcomer ME (2011) The structure of human 5-lipoxygenase. Science 331:217–219
Gillmor SA, Villaseñor A, Fletterick R, Sigal E, Browner MF (1997) The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. Nat Struct Mol Biol 4:1003–1009
GraphPad Software, La Jolla California USA, www.graphpad.com
Hadjipavlou-Litina DJ, Litinas KE, Kontogiorgis C (2007) The anti-inflammatory effect of coumarin and its derivatives. Anti-Inflamm Anti-Allergy Agents Med Chem 6:293–306
Holman TR, Zhou J, Solomon EI (1998) Spectroscopic and functional characterization of a ligand coordination mutant of soybean lipoxygenase-1: first coordination sphere analogue of human 15-lipoxygenase. JACS 120:12564–12572
Hoobler EK, Holz C, Holman TR (2013) Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases. Bioorg Med Chem 21:3894–3899
Hoult JRS, Paya M (1996) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gener Pharmacol 27:713–722
Huff JB, Merchant BT, Mullen CR, Venkata SRT (1999) U.S. Patent No. 5,998,593. Washington, DC: U.S. Patent and Trademark Office
Ivanov I, Heydeck D, Hofheinz K, Roffeis J, O’Donnell VB, Kuhn H, Walther M (2010) Molecular enzymology of lipoxygenases. Arch Biochem Biophys 503:161–174
Klil-Drori AJ, Ariel A (2013) 15-Lipoxygenases in cancer: a double-edged sword? Prostaglandins Other Lipid Mediat 106:16–22
Kobe MJ, Neau DB, Mitchell CE, Bartlett SG, Newcomer ME (2014) The structure of human 15-lipoxygenase-2 with a substrate mimic. J Biol Chem 289(12):8562–8569
Kostova I, Saso L (2013) Advances in research of Schiff-base metal complexes as potent antioxidants. Curr Med Chem 20:4609–4632
Kotali A, Nasiopoulou DA, Tsoleridis CA, Harris PA, Kontogiorgis CA, Hadjipavlou-Litina DJ (2016) Antioxidant Activity of 3-[N-(Acylhydrazono) ethyl]-4-hydroxy-coumarins. Molecules 21:138
Krönke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G, Baenckler HW (2009) 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 183:3383–3389
Kulkarni S, Das S, Funk CD, Murray D, Cho W (2002) Molecular basis of the specific subcellular localization of the C2-like domain of 5-lipoxygenase. J Biol Chem 277:13167–13174
Li HY, Gao S, Xi Z (2009) A colorimetric and “turn-on” fluorescent chemosensor for Zn (II) based on coumarin Shiff-base derivative. Inorg Chem Commun 12:300–303
Mascayano C, Espinosa V, Sepúlveda‐Boza S, Hoobler EK, Perry S (2013) In Vitro study of isoflavones and isoflavans as potent inhibitors of human 12‐and 15‐lipoxygenases. Chem Biol Drug Des 82:317–325
Mascayano C, Espinosa V, Sepúlveda‐Boza S, Hoobler EK, Perry S, Diaz G, Holman TR (2015) Enzymatic Studies of Isoflavonoids as Selective and Potent Inhibitors of Human Leukocyte 5‐Lipo‐Oxygenase. Chem Biol Drug Des 86:114–121
Miliauskas G, Venskutonis PR, Van Beek TA (2004) Screening of radical scavenging activity of some medicinal and aromatic plant extracts. Food Chem 85:231–237
Morris GM, Goodsell DS, Huey R, Olson AJ (1996) Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. Comput Aided Mol Des 10:293–304
Needleman P, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Annu Rev Biochem 55:69–102
Newcomer ME, Brash AR (2015) The structural basis for specificity in lipoxygenase catalysis. Protein Sci 24:298–309
Oldham ML, Brash AR, Newcomer ME (2005) Insights from the X-ray Crystal Structure of Coral 8R-Lipoxygenase calcium activation via a c2-like domain and a structural basis of product chirality. J Biol Chem 280:39545–39552
Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781–1802
Ribeiro D, Freitas M, Tomé SM, Silva AM, Porto G, Cabrita EJ, Marques MM, Fernandes E (2014) Inhibition of LOX by flavonoids: a structure–activity relationship study. Eur J Med Chem 72:137–145
Riendeau D, Falgueyret JP, Guay J, Ueda N, Yamamoto S (1991) Pseudoperoxidase activity of 5-lipoxygenase stimulated by potent benzofuranol and N-hydroxyurea inhibitors of the lipoxygenase reaction. Biochem J 274:287–292
Sarveswaran S, Chakraborty D, Chitale D, Sears R, Ghosh J (2015) Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. J Biol Chem 290:4994–5006
Da Silva CM, Da Silva DL, Modolo LV, Alves RV, De Resende MA, CVB Martins, De Fátima A (2011) Schiff bases: a short review of their antimicrobial activities. J Adv Res 2:1–8
Singh D, Pathak DP (2016) Coumarins: an overview of medicinal chemistry. Potential for new drug molecules. Int J Pharm Sci Rev Res 7:482
Skrzypczak-Jankun E, Zhou K, McCabe NP, Selman SH, Jankun J (2003) Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med 12:17–24
Somvanshi RK, Singh AK, Saxena M, Mishra B, Dey S (2008) Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences. BBA Proteins Proteom 1784:1812–1817
Srivastava P, Vyas VK, Variya B, Patel P, Qureshi G, Ghate M (2016) Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives. Bioorg Chem 67:130–138
Tomchick DR, Phan P, Cymborowski M, Minor W, Holman TR (2001) Structural and functional characterization of second-coordination sphere mutants of soybean lipoxygenase-1. Biochemistry 40:7509–7517
Torres R, Mascayano C, Nunez C, Modak B, Faini F (2013) Coumarins Of Haplopappus multifolius and derivative as inhibitors of LOX: evaluation in-vitro and docking studies. J Chil Chem Soc 58:2027–2030
Tresaugues L, Moche M, Arrowsmith CH, Berglund H, Busam RD, Collins R, Graslund, S (2008) Crystal structure of the lipoxygenase domain of human Arachidonate 12-lipoxygenase, 12S-type. Submitted. PDB entry 3D3L
Wecksler AT, Garcia NK, Holman TR (2009a) Substrate specificity effects of lipoxygenase products and inhibitors on soybean lipoxygenase-1. Bioorg Med Chem 17:6534–6539
Wecksler AT, Kenyon V, Garcia NK, Deschamps JD, van der Donk WA, Holman TR (2009b) Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2. Biochemistry 48:8721–8730
Wuest SJ, Horn T, Marti-Jaun J, Kühn H, Hersberger M (2014) Association of polymorphisms in the ALOX15B gene with coronary artery disease. Clin Biochem 47:349–355
Yoshiyuki K, Hiromichi O, Shigeru A, Kimiye B, Mitsugi K (1985) Inhibition of the formation of 5-hydroxy-6, 8, 11, 14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. BBA-Lipid Lipid Met 834:224–229
Acknowledgements
Financial support from DICYT 021641MC; Fondecyt 1120379, Fondecyt 1161375 and the Millennium Scientific Initiative (Grant P05-001-F).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Nuñez, C., Morales, N., García-Beltran, O. et al. Discovery two potent and new inhibitors of 15-lipoxygenase: (E)-3-((3,4-dihydroxybenzylidene) amino)-7-hydroxy-2H-chromen-2-one and (E)-O-(4-(((7-hydroxy-2-oxo-2H-chromen-3-yl) imino)methine) phenyl)dimethylcarbamothioate. Med Chem Res 26, 2707–2717 (2017). https://doi.org/10.1007/s00044-017-1968-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-1968-9